List of works - Catherine Beauchemin

(In)validating experimentally derived knowledge about influenza A defective interfering particles.

scientific article

A conservation law for virus infection kinetics in vitro

scientific article

A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.

scientific article

A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract

scientific article published on 13 April 2020

A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain.

scientific article published on 21 May 2015

A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead

scientific article

A simple cellular automaton model for influenza A viral infections.

scientific article published in January 2005

Assessing mathematical models of influenza infections using features of the immune response.

scientific article

Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model

scientific article

Characterizing T cell movement within lymph nodes in the absence of antigen

scientific article published on 01 May 2007

Design considerations in building in silico equivalents of common experimental influenza virus assays.

scientific article published on 19 January 2011

Duration of SHIV production by infected cells is not exponentially distributed: Implications for estimates of infection parameters and antiviral efficacy.

scientific article published on 16 February 2017

Exploring cell tropism as a possible contributor to influenza infection severity

scientific article (publication date: 23 November 2010)

Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture

scientific article

Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.

scientific article

Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling

scientific article

Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility

scientific article

Information processing mechanisms in microtubules at physiological temperature: Model predictions for experimental tests.

scientific article published on 11 April 2009

Kinetics of influenza A virus infection in humans

scientific article

Modeling amantadine treatment of influenza A virus in vitro.

scientific article published on 23 July 2008

Modelling endurance and resumption times for repetitive one-hand pushing.

scientific article published on 11 January 2018

Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms

scientific article published on 10 July 2017

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.

scientific article published on 21 October 2010

Probing the effects of the well-mixed assumption on viral infection dynamics.

scientific article published on 2 May 2006

Quantification of Ebola virus replication kinetics in vitro

scientific article published on 02 November 2020

Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model

scientific article

The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.

scientific article

The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients

scientific article

Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration

scientific article published on 18 October 2021

Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses

scientific article published on 15 April 2019

Viral factors in influenza pandemic risk assessment.

scientific article

List of works by Catherine Beauchemin

(In)validating experimentally derived knowledge about influenza A defective interfering particles.

A conservation law for virus infection kinetics in vitro

A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.

A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract

A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain.

A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead

A simple cellular automaton model for influenza A viral infections.

Assessing mathematical models of influenza infections using features of the immune response.

Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model

Characterizing T cell movement within lymph nodes in the absence of antigen

Design considerations in building in silico equivalents of common experimental influenza virus assays.

Duration of SHIV production by infected cells is not exponentially distributed: Implications for estimates of infection parameters and antiviral efficacy.

Exploring cell tropism as a possible contributor to influenza infection severity

Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture

Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.

Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling

Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility

Information processing mechanisms in microtubules at physiological temperature: Model predictions for experimental tests.

Kinetics of influenza A virus infection in humans

Modeling amantadine treatment of influenza A virus in vitro.

Modelling endurance and resumption times for repetitive one-hand pushing.

Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.

Probing the effects of the well-mixed assumption on viral infection dynamics.

Quantification of Ebola virus replication kinetics in vitro

Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model

The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.

The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients

Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration

Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses

Viral factors in influenza pandemic risk assessment.